Trial Outcomes & Findings for e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates (NCT NCT04987788)

NCT ID: NCT04987788

Last Updated: 2024-06-18

Results Overview

Screening colonoscopy completion status in medical charts six months after participants are enrolled in the study.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

42 participants

Primary outcome timeframe

Six months after enrollment

Results posted on

2024-06-18

Participant Flow

Participant milestones

Participant milestones
Measure
Motívate Group
Participants will engage with an app on an iPad, smartphone or computer. Motívate: The Motívate app can be used in English or Spanish and involves four sequential phases. 1) The engaging phase uses videos to welcome participants. 2) Patients willing to discuss the decision to have a screening colonoscopy will answer multiple-choice questions on colorectal cancer prevention - completing the focusing phase. Optional videos will offer additional information. 3) The evoking phase consists of interactive Motivational Interviewing exercises to help participants elicit motivations to get a screening colonoscopy. 4) During the planning phase, participants will view a video that will discuss the steps needed to prepare for the colonoscopy.
Control Group
Participant receive a link to watch a general health information video. Video link: General health information video link
Overall Study
STARTED
22
20
Overall Study
COMPLETED
22
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Motívate Group
n=22 Participants
Participants will engage with an app on an iPad, smartphone or computer. Motívate: The Motívate app can be used in English or Spanish and involves four sequential phases. 1) The engaging phase uses videos to welcome participants. 2) Patients willing to discuss the decision to have a screening colonoscopy will answer multiple-choice questions on colorectal cancer prevention - completing the focusing phase. Optional videos will offer additional information. 3) The evoking phase consists of interactive Motivational Interviewing exercises to help participants elicit motivations to get a screening colonoscopy. 4) During the planning phase, participants will view a video that will discuss the steps needed to prepare for the colonoscopy.
Control Group
n=20 Participants
Participant receive a link to watch a general health information video. Video link: General health information video link
Total
n=42 Participants
Total of all reporting groups
Age, Continuous
53.5 years
STANDARD_DEVIATION 8.14 • n=99 Participants
52.9 years
STANDARD_DEVIATION 5.82 • n=107 Participants
53.2 years
STANDARD_DEVIATION 7.05 • n=206 Participants
Sex: Female, Male
Female
11 Participants
n=99 Participants
13 Participants
n=107 Participants
24 Participants
n=206 Participants
Sex: Female, Male
Male
11 Participants
n=99 Participants
7 Participants
n=107 Participants
18 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
22 Participants
n=99 Participants
20 Participants
n=107 Participants
42 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=99 Participants
4 Participants
n=107 Participants
6 Participants
n=206 Participants
Race (NIH/OMB)
White
9 Participants
n=99 Participants
4 Participants
n=107 Participants
13 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
10 Participants
n=99 Participants
11 Participants
n=107 Participants
21 Participants
n=206 Participants

PRIMARY outcome

Timeframe: Six months after enrollment

Screening colonoscopy completion status in medical charts six months after participants are enrolled in the study.

Outcome measures

Outcome measures
Measure
Motívate Group
n=22 Participants
Participants will engage with an app on an iPad, smartphone or computer. Motívate: The Motívate app can be used in English or Spanish and involves four sequential phases. 1) The engaging phase uses videos to welcome participants. 2) Patients willing to discuss the decision to have a screening colonoscopy will answer multiple-choice questions on colorectal cancer prevention - completing the focusing phase. Optional videos will offer additional information. 3) The evoking phase consists of interactive Motivational Interviewing exercises to help participants elicit motivations to get a screening colonoscopy. 4) During the planning phase, participants will view a video that will discuss the steps needed to prepare for the colonoscopy.
Control Group
n=20 Participants
Participant receive a link to watch a general health information video. Video link: General health information video link
Colonoscopy Completion
19 Participants
19 Participants

Adverse Events

Motívate Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sarah Miller

Icahn School of Medicine at Mount Sinai

Phone: (212) 824-7783

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place